RAPT Therapeutics, Inc.

Direct answer

RAPT Therapeutics, Inc. is publicly traded on NASDAQ under the ticker RAPT.

RAPT Therapeutics, Inc. is a clinical-stage biopharmaceutical firm specializing in immunology. The company is dedicated to discovering, developing, and commercializing innovative oral small molecule therapies. These treatments are aimed at addressing critical unmet medical needs for patients battling oncology and inflammatory diseases. Its primary drug candidate for inflammation, RPT193, functions as a C-C motif...

Can you invest in RAPT Therapeutics, Inc.?

Yes. RAPT Therapeutics, Inc. is publicly traded on NASDAQ under the ticker RAPT.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for RAPT Therapeutics, Inc.

Detailed equity research is provided by MarketSnap.